bpc-157 randomized controlled trial humans musculoskeletal BPC-157: What the Science Actually Says What no one's telling you
Description
A multi-year study addressed this question
FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions
Step 7: Label and store Before you put the vial away, label it
Corticosteroids Corticosteroids provide rapid symptom relief but carry substantial risks: immunosuppression, impaired wound healing, tendon weakening with increased rupture risk, hyperglycemia, and osteoporosis with chronic use
Potential conflicts of interest: None reported
Most patients tolerate the injections well
